Scenario. Designing Test Menus for a Majority Population 8/13/2013. Your Faculty
|
|
- Rosa Green
- 5 years ago
- Views:
Transcription
1 Designing Test Menus for a Majority Population Your Faculty Ruth Cheng, MBA, MT(ASCP) Supervisor, Specimen Processing Area Department Of Pathology Penn State Hershey Medical Center, Hershey, PA Acknowledgements Amy J. Wendel Spiczka, HTL, MB, SCT(ASCP) Manager, Anatomic Pathology Department of Laboratory Medicine and Pathology Mayo Clinic Arizona For her peer review contributions Scenario We may be able to collaborate with local hospitals that use the same methodology. Perhaps we can exchange samples with them semiannually? We have been struggling with the quality of CAP specimens for our herpes simplex virus (by molecular amplification) proficiency tests. When I review the report, there is non consensus with the intended response. Do you have any ideas for improving our standings? 1
2 Designing Test Menus A test menu is a repository of validated assays that are available for clinician and patient consumption. A Strategically, well developed and optimally communicated test menu occurs. best practices for test ordering and triage are followed consistently best patient care and strong outcomes for quality and efficiency Designing Test Menus Designing a test menu involves a periodic review of services offered keeps cost efficiencies in check. New testing can Enhance current testing or be used as a standalone test. Improve Turnaround Time (TAT) Help with staff shortages. Improve safety. 2
3 Designing New Test Menus INTRODUCTION Step 1 Selection of Test Step 2 Test Research Step 3 Interacting with Vendors Step 4 Decision Special Requirements Step 5 & Test Step 6 Documentation Step 7 Training i Validation Learning Objectives INTRODUCTION Upon completion of this course, you should be able to Describe the steps for selection of a new test and design of a new test menu Discuss the importance of test menus in laboratory Discuss special requirements for test menu design Apply best practices for developing test menus 3
4 Collaboration STEP 1: SELECTION A collaborative effort by management and analytical experts including laboratory manager section supervisor technologist medical billing specialist information technology (IT) representative Selection Considerations STEP 1: SELECTION Selection considerations include 1. Test volumes (high vs. low) 2. Perform cost analysis (labor/supplies/expenses) 3. Review Return on Investment (ROI) 4. Proficiency and Quality Control testing 4
5 Published Test Menus STEP 1: SELECTION Components of a Published Test Menu include 1. Available assays 2. Turnaround Time (TAT) 3. Collection and storage requirements 4. Reference Ranges/Critical Values Preparatio n Prior to developing a test menu, analysis of new assays should include a review of ROI volumes equipment validation training compatibility/adaptabilit y 5
6 CAP Considerations College of American Pathologists (CAP) Considerations Intended response (Error rate comparison) Types of errors Need to network with other institutions and establish peer review process instead? Is there a well-communicated test menu that coincides with the activity menu? CAP Considerations Activity Menu Accuracy can be assessed by inquiry of responsible individuals id Inquiry and examination of the laboratory's test requisition(s) computer order screens procedure manuals patient reports 6
7 CAP Considerations Activity Menu All tests performed by the laboratory should be listed Unusual or esoteric tests may be identified as a miscellaneous code Further information may be found with the laboratory's instrumentation list CAP Considerations The specimen collection manual includes instructions for all of the following elements, as applicable Preparation of the patient Type of collection container and amount of specimen to be collected (i.e. nursing stations, clinics, physicians' offices) Need for special timing for collection (i.e. creatinine clearance) Types and amounts of preservatives or anticoagulants Need for special handling between time of collection and time received by the laboratory (i.e. refrigeration, immediate delivery) Proper specimen labeling Need for appropriate clinical data, when indicated Preservation and storage instructions 7
8 Examination of Existing Test Menus Important issues addressed on a particular test include laboratory space available reliability/quality service/support of vendors possibility of batching work costs (including cost per reportable test)/reimbursement/billing codes staffing requirements/training required pre-analytical variables performance (sensitivity and specificity) test complexity Food and Drug Administration (FDA) approval/clearance turnaround time reagents needed/waste produced physical requirements (i.e. temperature, humidity, lighting) Examination of Existing Test Menus What does the customer need? (i.e. accurate name of test, TAT, related requirements in other SOPs) For new test menus, examine related test menus For existing test menus, examine the current test menu and test results Determine test utilization (customer base and consumerism) Develop strategies for access Communication of laboratory tests Specimen collection Submission policies and procedures "Quality in a service or product is not what you put into it. It is what the client or customer gets out of it." Peter Drucker 8
9 Examination of Existing Test Menus How do orders come to the lab? Do all providers have access to the hospital EMR or do they review paper reports Providers do not necessarily know which reference lab will perform these tests. Do the reference lab reports come back to the hospital electronically, or by paper report? How does the paper p report get attached to the patient s medical record? Test Menu Information Test menu information should include the following Test Name Minimum Volume Alternate t Name Specimen Stability Clinical Significance Specimen Transport Patient Preparation Availability Additional Test Stat Availability Information TAT Specimen Type Reference Ranges Collection Critical Value Instructions Specimen Preparation 9
10 SOP Considerations SOPs provide the structural details for the development and maintenance of the test menu Appropriate instrumentation being utilized for the test volume Instrumentation efficiencies (running day shift only, twice a week, etc.) Analyze production data to establish a threshold for analytes. This review should be done annually and should include volume, cost, etc. Cost Analysis Review the following Will the test be performed on an existing platform or use a new methodology Direct costs including instrumentation, QC, calibrations, proficiency testing, disposable supplies, etc. Indirect costs including overhead and labor Pros and cons of performing test in house versus managing costs and reports when sent to a reference lab 10
11 Knowledge Check LEARNING ACTIVITY Test menu design is complex due to A. Clinician vs. Laboratory terminology differences B. Preferred vs. minimum volume requirements C. Transport times between collection and delivery to your facility D. All of the above Scenario Finance is requesting a review of our procedure costs in chemistry. This has not been done in 5 years, and we recently upgraded our instrumentation. What should I look at? <Click here to enter a response> Submit 11
12 Determining ROI STEP 3: WORKING WITH VENDORS How vendors can help to determine ROI of in-house testing Supply a list of labs using a specified product for peer review Labs can provide information about successes and deficiencies Free test kits Equipment Validation panels Training Determining ROI STEP 3: WORKING WITH VENDORS How vendors can help to determine ROI of in-house testing Vendors should be asked to showcase their product They should be interviewed while keeping an open mind Provide a list of goals and a timeline containing target dates Provide your best guesstimate of annual volumes 12
13 Knowledge Check LEARNING ACTIVITY Scenario Alex is considering changing methodologies for his coagulation tests. He has received input from his team about the possible costs involved, but, he is uncertain about what implementing the new instrument might mean. Proper cost analysis requires input from A. Medical director B. Lab supervisor C. Finance D. Clinician E. All of the above Knowledge Check LEARNING ACTIVITY Scenario] Alex is considering changing methodologies for his coagulation tests. Prior to implementation, he will need to A. Research instrumentation available B. Perform validation studies C. Update the test menu D. All of the above 13
14 Scenario STEPS 4 & 5: DECISION- MAKING & SPECIAL REQUIREMENTS That sounds like it is worth checking into. Thank you for being so observant. It is important, however, that we explore the possibility on several levels before making that decision. I have been looking at trends in our facility over the past 3 years Angela, there seems to be an increased patient need for Tacrolimus tests. Do you think we should incorporate them into our test menu? Scenario STEPS 4 & 5: DECISION- MAKING & SPECIAL REQUIREMENTS Yes, we will want to explore if the inquiries are about in house tests, or tests that are normally sent out to other reference labs. I can see if there is a trend on a national level as well. Are there other areas to consider? 14
15 Making the Decision STEP 4: DECISION- MAKING Which particular test or multiple products will best meet the specific needs of the laboratory? Consensus of research team and the laboratory director Allowing examination of contrasting views Laboratory director must be committed; she/he is ultimately responsible for the test s performance Must be approved by medical staff/administration demand cost/benefit analyses literature reviews patient impact FDA Requirements STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION Is the test FDA-approved or cleared? FDA-approved test a new test or test design that is different from current products for sale that has been approved by the FDA based on data from the manufacturer proving it is safe if used correctly FDA-cleared test a test that is similar to a current product for sale that has been approved by the FDA based on the manufacturer proving it is safe when used correctly 2 15
16 CLIA Requirements STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION Minimal requirements according to CLIA of 1988 State licensure and certification through CLIA is mandatory for clinical laboratories performing testing Accreditation through a deemed organization is voluntary. Accreditation organizations include College of American Pathologists (CAP), Joint Commission on Accreditation of Healthcare Organizations (JACHO) Commission on Office Laboratory Accreditation (COLA) HHS Requirements STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION Certificate from Department of Health and Human Services (HHS) Each procedure in the laboratory must be certified under at least of one of the following:³ Certificate of Waiver Certificate of Provider-Performed Microscopy Procedures (PPM) Certificate of Registration Certificate of Compliance Certificate of Accreditation 16
17 Waived and Non-Waived Testing STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION As stated in Harmening s Laboratory Management, the criteria used to determine method complexity are: 4 1. knowledge of personnel 2. training and experience 3. reagent and material preparation 4. characteristics of operational steps 5. calibration, QC and proficiency testing materials 6. test system troubleshooting 7. interpretation and judgment Waived and Non-Waived Testing STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION Non-waived Testing CLIA Inspection every two years Analysis of accuracy precision analytical sensitivity analytical specificity reportable range reference range In order to maintain its complexity level, the test can not be altered in any way 17
18 Waived and Non-Waived Testing STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION Waived Testing A test that is so uncomplicated erroneous results are negligible More testing that was previously non-waived is available to the laboratory and hospital personnel than ever before Waived tests must follow the manufacturer s instructions for Use QC quality assurance Peer Review Requirements STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION precision reportable range accuracy interferences Validation Study reference interval linearity recovery detection limit 18
19 Peer Review Requirements STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION Proficiency Requirements performed three times a year with five samples per challenge for each test performed by laboratory personnel using proficiency samples from the CAP or other deemed agency testing must be documented for inspections Peer Review Requirements STEP 5: SPECIAL REQUIREMENTS & TEST VALIDATION Proficiency Requirements An approved proficiency program must be implemented on all analytes that are on the regulated analyte list (found in Subpart I). Nonregulated analytes need testing through any proficiency program, or program developed in-house, and must be tested at least once every six months. This could comprise exchanging samples between local laboratories to fulfill the proficiency testing requirement. QC material is not a substitute for proficiency testing material. 19
20 Knowledge Check LEARNING ACTIVITY Which of the following statements is true? A. According to CAP, test menus must be comprehensive and include links to all tests available at your facility B. Test menus must be connected to the hospital information system C. Test menus should include pre-analytical information, including patient preparation and specimen processing requirements Multiple Choice LEARNING ACTIVITY When reviewing CAP proficiency test results, you must consider A. Intended response B. Your facility s response C. Your tech s performance D. Other participants responses E. All of the above 20
21 Scenario STEPS 6 & 7: DOCUMENTATION & TRAINING Thanks for all the work you have done on researching the assays, reviewing the specifications of the new immunohistochemistry tests in histology and preparing validation plans, Ben. The next step in designing our test menu to ensure its success will be documentation and training. My QC team and I will meet to begin working on the development of procedures to ensure the validity of the tests. I will also start work on a training plan and schedule and send it to you for approval soon. Documentation STEP 6 DOCUMENTATION Written policies and procedures including technical procedure QC log quality-assessment manual patient log inventory sheet discrepant results log training log temperature log 21
22 Documentation STEP 6: DOCUMENTATION Quality Assessment Manual responsible staff written procedures verification of results proficiency maintenance of all regulations Performance is monitored internally during staff training at 6 and 12 months (minimal) as required by CAP, and then annually thereafter. Competency is monitored externally through CAP proficiency testing and/or peer review. Staff Training STEP 7: TRAINING Lab Director is responsible for special requirements (i.e. requirements of accreditation agencies such as CLIA and COLA) determining appropriate personnel evaluation for competency proficiency testing oversight 22
23 Knowledge Check LEARNING ACTIVITY Test menu design is complex due to A. Clinician vs. Laboratory terminology differences B. Preferred vs. minimum volume requirements C. Transport times between collection and delivery to your facility D. All of the above Best Practices CONCLUSION Develop an accurate test menu that highlights the requirements needed by clinicians to choose tests wisely Support the development and deployment of a viable test menu through staff training and awareness, accurate SOPs and optimal communication Support the infrastructure test menu with necessary, high-quality, validated assays 23
24 References CONCLUSION 1. Current Population Survey. Outgoing Rotations Unicon Research Corporation. Available at: Accessed on: November 6, Food and Drug Administration. Getting to market with a medical device. Available at: Accessed on: November 15, CLIA Regulations. Sec Available at: wwwn.cdc.gov/clia/regs/toc.aspx. Accessed on: November 6, Harmening, DM. Laboratory Management: Principles and Processes. St. Petersburg, FL: DH Publishing & Consulting; 2007: College of American Pathologists. Proficiency Testing Performance. Available at: Viewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt{actionForm.contentReference}=laborat i t Ptlt{ ti F t tr l b t ory_accreditation%2fptes.html&_state=maximized&_pagelabel=cntvwr. Accessed on: November 6, Completion Requirements CONCLUSION You have successful completed the online learning course: Designing Test Menus for a Majority Population Credit is awarded upon successful completion of the post-test. Access the post-test by exiting the course and returning to the course content page. Click the link Post-Test to take the exam. You must score 80% in three attempts for credit to be awarded. Interested in applying these best practices on the job? You can download LMU Educational Tools and Resources from your Learning Plan in LMU. Please join the discussion in the Lab Management University online communities of practice. The more you participate and share, the more everyone can benefit including you and your team. 24
Plan Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail PRINCIPLE:
Subject Quality Assurance for Laboratory Testing Index Number Lab-0135 Section Laboratory Subsection Laboratory - General Category Departmental Contact Nancy Ekern Last Revised 7/27/2017 References Required
More informationUrinalysis and Body Fluids CRg. Laboratory Regulation. Laboratory Regulation for Quality Assessment. Unit 1 B. Quality Assessment
Urinalysis and Body Fluids CRg Unit 1 B Laboratory Regulation Federal Regulations / Regulatory Organizations Laboratory structure / operation Quality test performed by qualified personnel to obtain quality
More informationLaboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology
Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology Francis E. Sharkey, MD, FCAP University of Texas Health Science Center, San Antonio, TX Richard W. Brown, MD, FCAP Memorial
More informationToday s Featured Speaker
Today s Featured Speaker Judy Yost, M.A., M.T.(ASCP) received her B.S. Degree at Wilkes College and her M.A. in hospital management from Central Michigan University. She is an American Society for Clinical
More informationToday s Featured Speaker
Today s Featured Speaker Judy Yost, M.A., M.T.(ASCP) received her B.S. Degree at Wilkes College and her M.A. in hospital management from Central Michigan University. She is an American Society for Clinical
More informationMost Common POCT Deficiencies
LAP Audioconference Most Common POCT Deficiencies November 18, 2009 Cynthia Foss Bowman, MD, FCAP Chair, Point of Care Testing Resource Committee 2009 College of American Pathologists. Materials are used
More informationToday s Featured Speaker
Today s Featured Speaker Sandy Pearson, MBA, MT(ASCP): received her BS Degree at the University of Wisconsin and her MBA from St. Edwards University, Austin, TX. She is an American Society for Clinical
More informationEstablishing Quality Control Target Values and Standard Deviations for Hematology Instrumentation
Establishing Quality Control Target Values and Standard Deviations for Hematology Instrumentation For informational purposes only. WHO REQUIRES IT AND WHAT THEY REQUIRE Regulatory agencies require the
More informationCLIA Challenges in Laboratory Consolidation
CLIA Challenges in Laboratory Consolidation 5/1/18 Kandice Kottke-Marchant, MD, PhD Pathology & Laboratory Medicine Institute Eileen Pomiecko, HACP, CJCP Senior Director Regulatory Affairs Cleveland Clinic
More informationMarcia L. Zucker, Ph.D. ZIVD LLC
Marcia L. Zucker, Ph.D. ZIVD LLC 1 Two levels of liquid QC available from manufacturers Haphazard implementation 1990 s - POCT awareness increased Increased implementation of QC programs Expense of POCT
More informationAnn E. Snyder, MT (ASCP) CMS/CCSQ/SCG Div. of Laboratory Services CLIA
Ann E. Snyder, MT (ASCP) CMS/CCSQ/SCG Div. of Laboratory Services Discuss the regulations related to competency assessment Describe the 6 competency assessment requirements Provide some tips for meeting
More informationGuide to Fulfillment of Validation and Verification of Examination Requirements
DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 ext. 2635 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca
More informationAmerican Society of Cytopathology Core Curriculum in Molecular Biology
American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology Chapter 4 Stephanie A. Hamilton, EdD, SCT, MB(ASCP) CM MD Anderson
More informationCLIA Personnel & Competency Requirements
Friday April 7, 2017 D32 CLIA Personnel & Competency Requirements John T. Daly, MD, FCAP Chief Medical Officer, COLA DESCRIPTION: In addition to the laboratory director, the CLIA regulations specify personnel
More informationLaboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center
Laboratory Developed Tests William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Objectives Compare and contrast new test validation requirements for
More informationGuide to Fulfillment of Laboratory Results Comparability Requirements
DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 ext. 2635 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca
More informationIQCP Inspector Training Scenarios
Scenario 1: You are reviewing the product insert for a non-waived point of care blood gas analyzer that uses a cartridge for each patient sample to provide ph, po2 and pco2 results. The manufacturer s
More informationCase Study College of American Pathologists. All rights reserved. cap.org
Case Study How to Reduce Clerical Errors Mark Shearer, MCLT, MT(ASCP) Director of Chemistry, CompuNet Clinical Laboratories Clerical errors represent the single largest source of errors on proficiency
More informationDeveloping an Individualized Quality Control Plan (IQCP) For Cepheid s GeneXpert Diagnostic Systems
Developing an Individualized Quality Control Plan (IQCP) For BACKGROUND On January 1, 2014, the Center for Medicare and Medicaid Services (CMS) adopted an alternative Quality Control (QC) procedure that
More informationKaren Dyer MT(ASCP), DLM Daralyn Hassan MS, MT(ASCP) January 30, 2013
Karen Dyer MT(ASCP), DLM Daralyn Hassan MS, MT(ASCP) January 30, 2013 General overview of Guidance on regulations regarding waived testing Guidance on regulations regarding competency assessment for nonwaived
More informationWhat is? An Overview of Operational Processes
Friday April 7, 2017 LD4 What is? An Overview of Operational Processes John T. Daly, MD, FCAP Chief Medical Officer, COLA DESCRIPTION: This session focuses on other important topics for the laboratory
More informationEnsuring Compliance. When Adding a Specialty or Subspecialty. > LabGuide
Ensuring Compliance When Adding a Specialty or Subspecialty INTRODUCTION As you expand the services offered by your laboratory, you ll want to ensure your process for adding tests assures accurate and
More informationJune 2013 Clinical Laboratory News: Volume 39, Number 6
June 2013 Clinical Laboratory News: Volume 39, Number 6 Competency Assessment Does the New CLIA Guidance Mean Big Changes? By Bill Malone Laboratory professionals work in one of the most highly regulated
More informationMeaningful Competency Assessment
Friday April 7, 2017 D33 Meaningful Competency Assessment Kathy Nucifora, MPH, MT(ASCP) COLA, Accreditation Division Director Irwin Rothenberg, MBA, MS, MLS(ASCP) Technical Writer and Quality Advisor COLA
More informationNEW YORK STATE DEPARTMENT OF HEALTH CLINICAL LABORATORY EVALUATION PROGRAM. Crosswalk of Proposed Revision to General Systems Standards
Any General Systems Standards not addressed here remain in effect. (changes are underlined) CURRENT STANDARD CURRENT GUIDANCE PROPOSED STANDARD PROPOSED GUIDANCE Quality Management System Sustaining Standard
More informationCompetency Assessment: Is Your Program Competent? Judy Sullivan, MS, MT(ASCP)SBB HAABB Meeting April 30, 2013
Competency Assessment: Is Your Program Competent? Judy Sullivan, MS, MT(ASCP)SBB HAABB Meeting April 30, 2013 Objectives Discuss requirements related to competency assessment Describe what assessors, inspectors,
More informationThe Joint Commission's Most Challenging Standards and What you Can Do to Maintain Compliance
The Joint Commission's Most Challenging Standards and What you Can Do to Maintain Compliance Stacy Olea, MT(ASCP), FACHE Executive Director, Laboratory Program September 6, 2016 Objectives Identify the
More informationMeasurement Uncertainty Guide. ISO Accreditation Program
Measurement Uncertainty Guide ISO 15189 Accreditation Program Background Why This is Necessary The ISO 15189:2012 standard contains enhanced expectations regarding measurement uncertainty (MU) in clause
More informationProducts & Services. Catalog
Products & Services Catalog TLC Products & Services Laboratory Start-Up: Manual Templates and Teleconference Training Laboratory Start-Up: Customized Manuals and Onsite Training Laboratory Manual Templates
More informationHow Advances in Molecular Diagnostics Will Further Drive Consolidation of All Lab Testing. Executive War College 2013 New Orleans, LA
How Advances in Molecular Diagnostics Will Further Drive Consolidation of All Lab Testing Executive War College 2013 New Orleans, LA Discussion Points What s driving consolidation? What is the relationship
More informationMOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS. Richard L. Hodinka, Ph.D.
MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS Richard L. Hodinka, Ph.D. University of South Carolina School of Medicine Greenville Greenville Health System, Greenville, SC hodinka@greenvillemed.sc.edu
More informationCLIA Corner. In This Issue... Common Deficiencies. Proficiency Testing Personnel Micro Quality Control
CLIA Corner The University of Iowa Hygienic Laboratory First Quarter 2006 Iowa CLIA Surveyors: Nancy Grove, BS, MT(ASCP) & Kristine Rotzoll, BS, MT(ASCP) In This Issue... Common Deficiencies Proficiency
More informationTotal 170 files quick download in editable form by e delivery
Chapter-1.0 CONTENTS OF ISO 15189:2012 DOCUMENT KIT (More than 170 document files) The Total Editable Document kit has 6 main directories as below. ISO 15189:2012 Editable Document kit for medical laboratories
More informationLabGuide 13 How to Verify Performance Specifications
1 LG 13 Comments? Feedback? Questions? Email us at info@cola.org or call us at 800 981-9883 LabGuide 13 How to Verify Performance Specifications The verification of performance specifications confirms
More informationMolecular Diagnostics
Molecular Diagnostics Positioning the Laboratory for the Future Through Scalable Lab Developed Test Workflows, Clinical-level Quality, & Operational Efficiency Path to the heart of healthcare Change It
More informationTotal Analytic Error From Concept to Application
Página 1 de 5 Clinical Laboratory News Subscribe CLN Daily CLN Stat CLN Articles Total Analytic Error From Concept to Application Author: James O. Westgard, PhD, and Sten A. Westgard, MS // Date: SEP.1.2013
More informationQUALITY CONTROL/QUALITY ASSURANCE IN THE MOLECULAR MICROBIOLOGY LABORATORY
QUALITY CONTROL/QUALITY ASSURANCE IN THE MOLECULAR MICROBIOLOGY LABORATORY Richard L. Hodinka, Ph.D. University of South Carolina School of Medicine Greenville Greenville Health System, Greenville, SC
More information2013 Continuing Compliance Master Series Checklist Updates for Anatomic Pathology. Gerald A. Hoeltge, MD, FCAP July 17,
2013 Continuing Compliance Master Series Checklist Updates for Anatomic Pathology Gerald A. Hoeltge, MD, FCAP July 17, 2013 www.cap.org Today s Presenter Gerald A. Hoeltge, MD FCAP Chair, Checklists Committee
More informationTotal 170 files quick download in editable form by e delivery
Chapter-1.0 CONTENTS OF ISO 15189:2012 DOCUMENT KIT (More than 170 document files) The Total Editable Document kit has 6 main directories as below. ISO 15189:2012 Editable Document kit for medical laboratories
More informationIQCP : Where Do I Start? Developing a Successful IQCP: Let s Keep it Simple. Objectives 7/4/2015
Developing a Successful IQCP: Let s Keep it Simple Elia Mears, MHA MT(ASCP)SM Field Surveyor The Joint Commission Stacy Olea, MBA, MT(ASCP), FACHE Executive Director Laboratory Accreditation The Joint
More informationClosing the Gap in Pre-analytical Specimen Quality
Closing the Gap in Pre-analytical Specimen Quality Margaret Blaetz, CLC(AMT), CCCP(AAPOL) East Coast Clinical Consultants, LLC February 27, 2018 Learning objectives Explain the importance of proper collection,
More informationLeveraging ISO s Quality Management System to Achieve 24/7 Inspection Readiness. Randy Querry Accreditation Manager Clinical
Leveraging ISO 15189 s Quality Management System to Achieve 24/7 Inspection Readiness Randy Querry Accreditation Manager Clinical Goals Provide brief background on A2LA Differentiate between CLIA and ISO
More informationCollege of American Pathologists. Statement to the National Institutes of Health on the proposed Genetic Testing Registry.
College of American Pathologists Statement to the National Institutes of Health on the proposed Genetic Testing Registry July 12, 2010 College of American Pathologists 1350 I Street, NW, Suite 590 Washington,
More informationProficiency Testing Turning Pitfalls into Positive Outcomes
Proficiency Testing Turning Pitfalls into Positive Outcomes Presented by: Margaret Blaetz, CLC, MLT(AMT), CCCP(AAPOL) CEO/Technical Consultant East Coast Clinical Consultants, LLC National Manager of Laboratory
More informationSo You Want to Develop a Test? Navigating the Regulatory Waters of Laboratory Developed Testing
So You Want to Develop a Test? Navigating the Regulatory Waters of Laboratory Developed Testing Professor of Pathology, Microbiology, and Immunology Associate Medical Director of Clinical Operations Medical
More informationA2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017
Laboratory Page 1 of 17 Laboratory December 6, 2017 2017 by A2LA All rights reserved. No part of this document may be reproduced in any form or by any means without the prior written permission of A2LA.
More informationANNEX H Vendor Questionnaire: Important Considerations for Service Contract Negotiations Laboratories should ask vendors the following questions:
ANNEX H Vendor Questionnaire: Important Considerations for Service Contract Negotiations Laboratories should ask vendors the following questions: QUESTIONS YES NO Equipment Installation Are there pre-installation
More informationCoaching for Performance Improvement
Coaching for Performance Improvement Your Faculty Kristin Marriott Director of Support Services APP-UniPath, LLC Acknowledgements Jean Marie Marden, MA, CFP Vice President, Human Resources & Development
More informationCurrent Topics in NYS Clinical Laboratory Oversight
June 13, 2018 1 Current Topics in NYS Clinical Laboratory Oversight Derek Symula, Ph.D. and Stephanie Shulman, MPH, MS, MT (ASCP) June 13, 2018 2 (i) Clinical Laboratory Reference System (CLRS) to monitor,
More informationCAP Regulatory Potpourri for Microbiologists. Christi Wojewoda, MD Director of Clinical Microbiology 2/2/19
CAP Regulatory Potpourri for Microbiologists Christi Wojewoda, MD Director of Clinical Microbiology 2/2/19 Disclosures Vice Chair of the CAP Microbiology Committee Immediate Past Vice Chair of the CAP
More informationAPPENDIX C SURVEY PROCEDURES AND INTERPRETIVE GUIDELINES FOR LABORATORIES AND LABORATORY SERVICES
APPENDIX C SURVEY PROCEDURES AND INTERPRETIVE GUIDELINES FOR LABORATORIES AND LABORATORY SERVICES SURVEY PROCEDURES AND INTERPRETIVE GUIDELINES FOR LABORATORIES AND LABORATORY SERVICES Part 1 Policy for
More informationSeptember 8, General Comments:
September 8, 2009 AMP Comments on the draft report from the Agency for Healthcare Research and Quality (AHRQ): AHRQ Draft Report on Quality, Regulation and Clinical Utility of Laboratorydeveloped Tests.
More informationCompetency Assessment
Competency Assessment Is Your Lab s Competency Assessment a Competent Assessment? Presented by: Jean Ball MBA, MT(HHS), MLT(ASCP) December 9, 2014 cap.org v. # Oh the places we ve been 2014 College of
More informationHow to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations. The complete guide to developing or expanding your lab
How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations The complete guide to developing or expanding your lab Includes step-by-step plans for basic and full-service MDx
More informationSLMTA Management Framework Page 1
LABORATORY MANAGEMENT FRAMEWORK SLMTA Management Framework Page 1 JOB TASK LIST LEVEL I Distinguishing Characteristics: These people manage themselves at their sites, even though they may not have supervisor
More informationIQCP for Streamlined ID QC of Vitek 2
IQCP for Streamlined ID QC of Vitek 2 Facility: EXAMPLE Test System: Vitek 2 Commercial Identification System Test System Primary SOPs include: GENERAL PROCEDURES: Quality Control for AST Cards and Identification
More informationTHE ESSENTIAL ELEMENT of a
THE ESSENTIAL ELEMENT of a Successful Laboratory LabDAQ Laboratory Information System (LIS) is a scalable SOLUTION trusted by thousands of physicians and laboratory professionals every day. Experience
More informationDisclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs
Disclosures FDA Regulation of Laboratory Developed Tests Beaumont Health System, 24 th Annual Symposium on Molecular Pathology September 16, 2015 Roger D. Klein, MD JD Director, Molecular Pathology Clinical
More informationDiagnostic Laboratory New Facility Registration Pre-Assessment Data Verification Form
Diagnostic Laboratory New Facility Registration Pre-Assessment Data Verification Form Notes and Instructions: Section 4: For submission of required documentation, embed document into table beside the specific
More informationMolecular Diagnosis Challenges & Solutions. Using Molecular Kits or Laboratory Developed Tests (Home Brew), Emphasis on Validation
Using Molecular Kits or Laboratory Developed Tests (Home Brew), Emphasis on Validation Molecular Diagnosis Challenges & Solutions Behzad Poopak, DCLS PhD Tehran Medical Branch- Islamic Azad University
More informationRE: Draft Local Coverage Determination Molecular Diagnostic Tests (MDT) (DL33599)
December 17, 2014 Elaine Jeter, MD Medical Director Palmetto GBA PO Box 100190 Columbia, SC 29202 elaine.jeter@palmettogba.com J11B.policy@PalmettoGBA.com RE: Draft Local Coverage Determination Molecular
More information- - - Backup_Lab_Guidelines v
- - - Backup_Lab_Guidelines v2.0 2010-11-10 Table of Contents Introduction... 1 Back-Up Guidelines for Safety Testing Laboratories... 2 Introduction... 2 Development and review of the back-up plan... 2
More informationAPFCB. Improving Laboratory Performance Through Quality Control. Designing an Appropriate QC Procedure for Your Laboratory QUALITY CONTROL
APFCB Improving Laboratory Performance Through Quality Control Designing an Appropriate QC Procedure for Your Laboratory - Five simple steps for QC success By Sarah Kee, BSc PGCE QC Scientific Consultant,
More informationImplementation Guide. 3a. Skills Checklist. 3b. Competency Exam. 3c. Answer Key: Competency Exam. 3d. Competency Assessment Checklist
Implementation Guide TABLE OF CONTENTS SECTION 1 Introduction SECTION 2 Pre-Implementation Checklist SECTION 3 Introduction: Operator Training and Competency Certification 3a. Skills Checklist 3b. Competency
More informationAvoiding the Most Frequent Joint Commission Laboratory Survey Findings using Robust Process Improvement Tools (RPI) AVOIDING THE MOST
Avoiding the Most Frequent Joint Commission Laboratory Survey Findings using Robust Process Improvement Tools (RPI) AVOIDING THE MOST FREQUENT JOINT COMMISSION LABORATORY SURVEY FINDINGS USING ROBUST PROCESS
More informationCollege of American Pathologists Laboratory Accreditation Program. AP for Histotechs and Secretaries. Learning Objectives
College of American Pathologists AP for Histotechs and Secretaries Francis E. Sharkey, M.D., FCAP University of Texas Health Science Center - San Antonio February 20th, 2008 Copyright 2008 College of American
More informationHOW TO WRITE A REQUEST FOR PROPOSAL FOCUSING ON A VALUE-BASED MODEL
HOW TO WRITE A REQUEST FOR PROPOSAL FOCUSING ON A VALUE-BASED MODEL A well-designed proposal can be the difference between an accurate and clear view of a reference laboratory partner and a lengthy document
More informationExample # 2. IQCP for Antimicrobial Susceptibility Testing (AST) Test System: Beckman Coulter Microscan Walkaway 96. Facility: Written by: Date:
IQCP for Antimicrobial Susceptibility Testing (AST) Test System: Beckman Coulter Microscan Walkaway 96 Facility: Written by: Date: Implementation Date: This risk assessment and IQCP plan has been approved
More information9/2/15 (replaces 5/31/15 version) Page 1
Please note that some references to protocol, publications, performance data etc. are fictitious in this EXAMPLE. Please use your own DATA for your IQCP. The following represents one example of how you
More informationWhat is an LDT? The Do s s And Don ts of Validating Laboratory Developed Tests
The Do s s And Don ts of Validating Laboratory Developed Tests Deirdre Astin, MS, MT (ASCP) Lab Quality Confab 2011 November 2011 San Antonio Texas What is an LDT? Laboratory developed tests (LDTs) are
More informationCommon Deficiencies
Question text Deficiency #12: Does the laboratory have a documented system to ensure consistency of morphologic observations among all personnel performing (U/A, Micro, Hem) (sample) Suggested methods
More informationIQCP for Commercial Antimicrobial Susceptibility Testing (AST) System XYZ
Please note that some references to protocol, publications, performance data etc. are fictitious in this EXAMPLE. Please use your own DATA for your IQCP. The following represents one example of how you
More information2015 Focus on Compliance What You Really Need to Know About the Individualized Quality Control Plan (IQCP) and Ensuring Your Laboratory s Compliance
The Individualized Quality Control Plan (IQCP): what you need to know to ensure compliance Deborah Perry, M.D. Objectives Describe changes to the quality control regulations Explain how the CAP has implemented
More informationGuidelines for Use of Back-Up Equipment and Back-up Clinical Laboratories for Safety Testing in DAIDS-Sponsored Clinical Trials
Notes An earlier version of this document was drafted by Paul Richardson, Estelle Piwowar-Manning, Erin Gover, and Kurt Michael. The document was finalized by the Cross-Network Laboratory Focus Group (LFG),
More informationIQCP for the Akers Bio PIFA PlussPF4 Rapid Assay
On December 31, 2015 the ability to use Equivalent Quality Control (EQC) policies will expire. Laboratories will be required to either follow the quality control regulations as outlined in CLIA 88 or develop
More informationDIAGNOSTIC ACCREDITATION PROGRAM Howe Street Telephone: MEMORANDUM
DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca Fax:
More informationThe PCL Alverno Difference Quality Driven Patient Focused Elevating the clinical laboratory and diagnostic capabilities of hospitals and healthcare
The PCL Alverno Difference Quality Driven Patient Focused Elevating the clinical laboratory and diagnostic capabilities of hospitals and healthcare providers. Our Journey to Implement the Culture of Continuous
More information2015/05/02 Sharon Crafter
IS THERE A CRISIS IN CYTOTECHNOLOGY IN ONTARIO: COMPETENCIES FOR THE FUTURE May 2015 Objectives Describe what we know about the past, current and evolving environment of the practice of cytopathology Identify
More informationTestStream for Epic Hyperspace
TestStream for Epic Hyperspace Keep your health care systems in check TestStream provides definitive validation of the quality and risk levels of your clinical healthcare systems. Comprehensive testing
More informationADDENDUM 2. I. The following are revisions to the general information provided in the RFP 744-R1715 posted March 21, 2017:
ADDENDUM 2 DATE: April 4, 2017 PROJECT: Lab Information System (LIS) and Data Migration RFP NO: 744-R1715 OWNER: TO: The University of Texas Health Science Center at Houston Prospective Bidders I. The
More informationWrap Up Summary CMC Strategy Forum. Bridging Analytical Methods Jan 27, 2014
Wrap Up Summary CMC Strategy Forum Bridging Analytical Methods Jan 27, 2014 Common Messages Industry and Regulatory Method lifecycle includes several elements that occur over time as needed to assure accurate,
More informationPioneers in Quality. Joint Commission 2018 ecqm Direct Data Submission Platform: Your Questions Answered. Tricia Elliott, MBA, CPHQ.
Joint Commission 2018 ecqm Direct Data Submission Platform: Your Questions Answered Tricia Elliott, MBA, CPHQ July 24, 2018 Background of DDSP The Joint Commission Direct Data Submission Platform 2 2018,
More informationLMU TEACHING TOOLS. Personnel. LAB Fundamentals. Job Description MANAGEMENT CERTIFICATE OF COMPLETION PROGRAM
LMU TEACHING TOOLS LAB Fundamentals MANAGEMENT CERTIFICATE OF COMPLETION PROGRAM Course Essentials Program for Syllabus Creating a Laboratory Job Description Hours for Completion: 25 Type of Instruction:
More informationPractitioner Certificate of Competence for Genetic Technologists
Practitioner Certificate of Competence for Genetic Technologists Guidance for applicants Version 2.0 Review date: 1 September 2016 Introduction This Guide supports an applicant completing an application
More informationIQCP for Disk Diffusion Antimicrobial Susceptibility Testing (AST)
IQCP for Disk Diffusion Antimicrobial Susceptibility Testing (AST) Test System: Disk Diffusion Antimicrobial Susceptibility Testing (Kirby Bauer) / Twelve Disk Diffusion Test using BBL Disks Facility:
More informationPrepared by Date Adopted Supersedes Procedure # Adapted from HPTN Policy. Review Date Revision Date Signature
APPENDIX IV: LABORATORY QUALITY CONTROL POLICY Prepared by Date Adopted Supersedes Procedure # Adapted from HPTN Policy N/A Review Date Revision Date Signature Distributed to # of Copies Distributed to
More informationOrchard Software More than 25 Years Dedicated to Laboratories.
Orchard Software More than 25 Years Dedicated to Laboratories 1 About Orchard Software...Comprehensive Software Solutions for Labs of All Shapes & Sizes Highly Configurable & Flexible Software Decorated
More informationAn innovative approach to genetic testing for improved patient care
An innovative approach to genetic testing for improved patient care Blueprint Genetics Blueprint Genetics is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge Who we
More informationIQCP for the Akers Bio PIFA Heparin Platelet Factor 4 Rapid Assay
On December 31, 2015 the ability to use Equivalent Quality Control (EQC) policies will expire. Laboratories will be required to either follow the quality control regulations as outlined in CLIA 88 or develop
More informationQuality Control and Monitoring of Molecular Tests Gregory J. Tsongalis, Ph.D.
Quality Control and Monitoring of Molecular Tests Gregory J. Tsongalis, Ph.D. Professor of Pathology Director, Molecular Pathology Dartmouth Medical School Dartmouth Hitchcock Medical Center Norris Cotton
More informationPlease consult the Product Package Insert before running the test
Please consult the Product Package Insert before running the test Sample Collection, Preparation, Storage and Volume Q. What type of blood sample should be used with the PIFA Heparin/PF4 Rapid Assay? A.
More informationQuality Assurance by Liz McChlery
Quality Assurance by Liz McChlery Define QA and Total Quality Management Describe Quality Control Define and distinguish Accuracy and Precision Define a Biological Reference Interval Describe ISO15189
More informationGuidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy
Guidance for Industry and FDA Staff Replacement Reagent and Instrument Family Policy Document issued on: December 11, 2003 This document supersedes Data for Commercialization of Original Equipment Manufacturers
More informationPoint of Care Testing in Clinical Trials
Point Of Care Testing in Clinical Trials Page 1 Point of Care Testing in Clinical Trials Point of Care Testing Point of care (POC) testing is diagnostic testing performed promptly and conveniently in the
More informationS1725 Method Validation and Verification: Case Studies and Laboratory Challenges
S1725 Method Validation and Verification: Case Studies and Laboratory Challenges James H. Nichols, PhD, D(ABCC) Lauren N. Person, DO, MPH, FCAP Objectives Identify the difference between method validation
More informationA New Era of Clinical Diagnostics: How the Business Model is Changing.
A New Era of Clinical Diagnostics: How the Business Model is Changing. Nancy J Kelley, President and CEO of Nancy J Kelley & Associates Remarks to BTIG Emerging Technologies in Healthcare Diagnostics September
More informationOverview of the FDA Approval Process for TB Diagnostics
Overview of the FDA Approval Process for TB Diagnostics Steven Gitterman, M.D., Ph.D. Division of Microbiology Devices Center for Devices and Radiological Health FDA Definition: In Vitro Diagnostic Device
More informationRegulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC
Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,
More informationLucia M. Berte Laboratories Made Better! P.C. Broomfield, Colorado, USA
Raising the Bar on Lab Quality: Understanding the Lab Test Life Cycle, Its Role in Your Lab's Recurring Cost of Bad Quality, and Proven Steps to Boost Quality while Reducing Cost Lucia M. Berte Laboratories
More information